ATC Group: V09IX06 Sodium fluoride (18F)

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of V09IX06 in the ATC hierarchy

Level Code Title
1 V Various
2 V09 Diagnostic radiopharmaceuticals
3 V09I Tumour detection
4 V09IX Other diagnostic radiopharmaceuticals for tumour detection
5 V09IX06

Active ingredients in V09IX06

Active Ingredient Description
Sodium fluoride ยนโธF

Sodium fluoride F18 is a radioactive diagnostic agent for positron emission tomography (PET) indicated for imaging of bone to define areas of altered osteogenic activity. Increased fluoride F18 ion deposition in bone can occur in areas of increased osteogenic activity during growth, infection, malignancy (primary or metastatic) following trauma, or inflammation of bone.

Medicines in this ATC group

Austria (AT)

Estonia (EE)

France (FR)

Poland (PL)

Turkey (TR)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.